BeOne Newsroom

Media Resources

Corporate Press Kits
Review resources about BeOne.

Product & Pipeline Media Resources
Find information about our approved medicines and pipeline molecules.

Media Library
View and download images of our leaders, facilities, company logo and other corporate assets.
Press Releases
Read our latest news.
- August 18, 2026
BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries
- August 10, 2026
BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration
- August 5, 2026
BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates
- July 23, 2026
BeOne Medicines Expands U.S. Manufacturing with Total Investment of More Than $1 Billion to Advance Innovative Cancer Medicines
- July 17, 2026
BeOne Medicines to Announce Second Quarter 2026 Financial Results on August 5
- June 30, 2026
BeOne Medicines Announces Positive Phase 3 Results for BRUKINSA in Frontline Mantle Cell Lymphoma
- June 24, 2026
Blood Cancer United and BeOne Medicines Announce Expanded Partnership to Advance Patient Support and Community for People Impacted by Blood Cancer
- June 12, 2026
BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026
- June 11, 2026
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit
- June 1, 2026
BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026
- May 29, 2026
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 2026
- May 27, 2026
BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 2026

Congress Hub
Review the latest information about the data we’re presenting and where you can find us.

Responsible Business & Sustainability Report
Responsible Business & Sustainability is at the core of everything we do to positively impact the lives of patients and society.
Explore More

Our Pipeline
Our cancer pipeline is one of the most promising and prolific in the industry.